OpenAI chief Sam Altman on Friday said his high-profile artificial intelligence company is "on the wrong side of history" ...

CEO of the ChatGPT maker says his company has been “on the wrong side of history” with open-source software.

It's a wet Friday out there in San Francisco. Don't let the day's business news float by. Read what's surfacing at week's end ...

(Reuters) - OpenAI CEO Sam Altman called Chinese startup DeepSeek's R1 AI model "impressive" on Monday, but emphasized that ...

It’s an early step for OpenAI into the vaguely defined category of AI “ agents ,” which are intended to carry out multi-step ...

Three policy wonks dissect President Donald Trump’s executive orders on border security, immigration, government efficiency ...

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT reports. © 2024 TechCrunch. All rights reserved. For personal use only.

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

What's trending in Bay Area business news this Friday morning: Twilio, EA Sports, Headlands Brewing, GameOn, 345 California, Retro Biosciences and more.

(Reuters) - Databricks said on Wednesday Meta Platforms had joined as an investor in a $10 billion funding round intended to ...

CEO Sam Altman confirmed the development on Friday via a post on social media platform X. The rollout will include both the application programming interface (API) and an updated version of ...

OpenAI, led by CEO Sam ... San Francisco’s transition team. In addition to hosting a fundraiser for Democratic presidential candidate Andrew Yang at his San Francisco home in late 2019, Altman ...